Eli Lilly’s latest weight loss drug candidate, retatrutide, is already being talked about as a potential game changer in ...

In the first head-to-head trial of Ozempic versus Eli Lilly's new "King Kong" drug retatrutide, the next-generation drug led ...

Lilly reports that retatrutide achieved greater weight loss and blood sugar reduction than Ozempic 2 mg in an 80-week type 2 ...

By Sriparna Roy Oct 28 (Reuters) - Eli Lilly said on Wednesday its experimental next-generation obesity drug, retatrutide, ...

Eli Lilly’s next generation weight loss drug, known as retatrutide, was shown to provide more than double the weight loss of ...

An experimental weight-loss drug from Eli Lilly led to more than twice the average weight loss of Ozempic in a clinical trial ...

Once-weekly retatrutide induced greater declines in HbA1c and body weight than Ozempic 2 mg for adults with type 2 diabetes, ...

The ‘triple G’ experimental drug also led to greater reductions in A1C. Drugmaker Lilly is expected to apply for FDA approval ...

Eli Lilly's experimental weight-loss drug retatrutide outperformed Ozempic in a clinical trial, but FDA approval is still ...

A separate survey found that 72% of weight-loss drug users had changed clothing sizes, while 46% had switched apparel brands.

Chrissy Metz detailed the health benefits she has experienced since starting to use a GLP-1 medication, with the This Is Us ...